Cargando…
Non-secretory multiple myeloma: from biology to clinical management
Multiple myeloma (MM) is the second most common hematologic malignancy in the US. It is typically characterized by production of large amounts of defective immunoglobulin (Ig). Diagnosing MM and monitoring treatment response, including eventual relapse, are largely based on sequential measurements o...
Autores principales: | Dupuis, Megan Murray, Tuchman, Sascha A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171196/ https://www.ncbi.nlm.nih.gov/pubmed/28008276 http://dx.doi.org/10.2147/OTT.S122241 |
Ejemplares similares
-
A Case Report of Non-secretory Multiple Myeloma
por: Kelley, Maria A, et al.
Publicado: (2022) -
Non-Secretory Myeloma: Ready for a new Definition?
por: Corso, Alessandro, et al.
Publicado: (2017) -
Epstein–Barr virus mucocutaneous ulcer followed by Hodgkin lymphoma in multiple myeloma patient
por: Forster, Moriah, et al.
Publicado: (2022) -
Non Secretory Multiple Myeloma With Extensive Extramedullary Plasmacytoma: A Diagnostic Dilemma
por: Low, Soo Fin, et al.
Publicado: (2015) -
Non Secretory Multiple Myeloma With HCV Infection: A Rare Case Entity
por: Puri, Arun, et al.
Publicado: (2018)